People: Depomed Inc (DEPO.O)

DEPO.O on Nasdaq

14.72USD
19 Sep 2014
Price Change (% chg)

$-0.24 (-1.60%)
Prev Close
$14.96
Open
$15.00
Day's High
$15.13
Day's Low
$14.67
Volume
2,122,093
Avg. Vol
1,275,153
52-wk High
$15.51
52-wk Low
$6.95

Search Stocks

Dawes, Karen 

Brief Biography

Ms. Karen A. Dawes is Independent Director of Depomed, Inc., since April 2008. Since 2003, Ms. Dawes has served as President of Knowledgeable Decisions, LLC, a pharmaceutical consulting firm that she founded. Between 1999 and 2003, Ms. Dawes served as Senior Vice President and U.S. Business Group Head for Bayer Corporation's U.S. Pharmaceuticals Group. Prior to joining Bayer, she served as Senior Vice President, Global Strategic Marketing for Wyeth, formerly known as American Home Products, where she held responsibility for worldwide strategic marketing. She also served as Vice President, Commercial Operations for Genetics Institute, Inc., which was acquired by Wyeth in 1997. Ms. Dawes began her pharmaceutical industry career at Pfizer, Inc. where, from 1984 to 1994, she held a number of positions in Marketing, serving most recently as Vice President, Marketing of the Pratt Division. Ms. Dawes currently serves as a director of Repligen Corporation and several private companies. Ms. Dawes holds an M.B.A. from Harvard University, and B.A. and M.A. degrees from Simmons College.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks